Freyssinet J M, Wiesel M L, Grunebaum L, Pereillo J M, Gauchy J, Schuhler S, Freund G, Cazenave J P
Unité 311 INSERM, Centre Régional de Transfusion Sanguine, Strasbourg, France.
Biochem J. 1989 Jul 15;261(2):341-8. doi: 10.1042/bj2610341.
The activation of protein C by thrombin is thought to occur at the endothelial cell surface in the presence of an essential membrane glycoprotein cofactor, thrombomodulin. In the present study it is demonstrated that, in the presence of hirudin, the most potent known inhibitor of thrombin, human protein C can be activated by human factor Xa (20 nM), but by a thrombomodulin-independent mechanism requiring only the presence of Ca2+ and phospholipid vesicles bearing a high proportion of negative charges (30-75% phosphatidylserine, depending on the conditions). At an optimal concentration of phosphatidylserine/phosphatidylcholine (1:1, w/w) of 75 microM, the apparent Km was 1 microM with a kcat. of 1 min-1. At 25 microM-phospholipid the Km was unchanged and the kcat. was 0.67 min-1. At either lipid concentration, increasing the density of negative charges by the adjunction of sulphated polysaccharides, like pentosan polysulphate or standard heparin at optimal concentrations of 2-5 micrograms/ml and 5-10 micrograms/ml respectively, resulted in a 4-fold increase of the kcat. without affecting the Km. Sulphated polysaccharides alone were poor promoters of protein C activation by factor Xa. In any case the presence of Ca2+ was essential, the dependence being sigmoidal with Hill coefficients ranging from 1.4 to 2.0. No significant activation of 4-carboxyglutamic acid-domainless protein C, a chymotrypic derivative lacking the phospholipid-binding domain, could be detected in the presence of phospholipids and Ca2+, with or without pentosan polysulphate. In a large molar excess, other phospholipid-binding entities like prothrombin fragments F1 or F1+2 could inhibit protein C activation by factor Xa, but pentosan polysulphate exerted a clear protective effect. Factor Xa irreversibly inhibited at its active centre, but not di-isopropyl phosphoro-thrombin, behaved as an inhibitor but in a more complex manner than simple Michaelis-Menten kinetics. Among several derivatives of pentosan polysulphate or of heparin which were tested, those having the higher degree of sulphation and/or molecular mass were the most efficient in enhancing the rate of activation of protein C by factor Xa in the presence of phospholipids. These results suggest that human factor Xa, at physiological concentrations, could activate human protein C in the presence of anionic phospholipids and that this activation could be potentiated by therapeutic concentrations of sulphated polysaccharides.
凝血酶对蛋白C的激活作用被认为是在内皮细胞表面,在一种必需的膜糖蛋白辅因子血栓调节蛋白存在的情况下发生的。在本研究中,已证明在水蛭素(已知最有效的凝血酶抑制剂)存在的情况下,人蛋白C可被人因子Xa(20 nM)激活,但通过一种不依赖血栓调节蛋白的机制,该机制仅需要Ca2+和带有高比例负电荷的磷脂囊泡(30 - 75%磷脂酰丝氨酸,取决于条件)的存在。在磷脂酰丝氨酸/磷脂酰胆碱的最佳浓度(1:1,w/w)为75 microM时,表观Km为1 microM,kcat为1 min-1。在25 microM磷脂时,Km不变,kcat为0.67 min-1。在任一脂质浓度下,通过添加硫酸化多糖(如戊聚糖多硫酸盐或标准肝素,最佳浓度分别为2 - 5微克/毫升和5 - 10微克/毫升)增加负电荷密度,导致kcat增加4倍,而不影响Km。单独的硫酸化多糖是因子Xa激活蛋白C的不良促进剂。在任何情况下,Ca2+的存在都是必不可少的,其依赖性呈S形,希尔系数范围为1.4至2.0。在磷脂和Ca2+存在的情况下,无论有无戊聚糖多硫酸盐,均未检测到4 - 羧基谷氨酸无结构域蛋白C(一种缺乏磷脂结合结构域的胰凝乳蛋白酶衍生物)的显著激活。在大量摩尔过量的情况下,其他磷脂结合实体如凝血酶原片段F1或F1 + 2可抑制因子Xa对蛋白C的激活,但戊聚糖多硫酸盐具有明显的保护作用。在其活性中心被不可逆抑制的因子Xa,而不是二异丙基磷酰凝血酶,表现为抑制剂,但比简单的米氏动力学更复杂。在测试的几种戊聚糖多硫酸盐或肝素衍生物中,那些具有较高硫酸化程度和/或分子量的衍生物在磷脂存在的情况下,对增强因子Xa激活蛋白C的速率最为有效。这些结果表明,在生理浓度下,人因子Xa在阴离子磷脂存在的情况下可激活人蛋白C,并且这种激活可被治疗浓度的硫酸化多糖增强。